CORONA Main Coronavirus thread

Expert: Chinese Scientists Sell Lab Animals as Meat on the Black Market

A Chinese researcher injects a monkey with an experimental solution at a laboratory in the southern Chinese city of Guangzhou 28 May 2004. China is drafting new regulations to save laboratory animals from unnecessary pain and inhumane treatment, as part of an overall set of guidelines on animal testing, encourage …

STR/AFP via Getty Images
By John Hayward 24 Feb 2020

Population Research Institute President Steven W. Mosher wrote at the New York Post on Saturday that China’s coronavirus epidemic could have been unleashed by researchers who sold laboratory animals to the notorious “wet markets” of Wuhan for extra cash.

Mosher is not the first skeptic of Beijing’s official coronavirus narrative to note the presence of an advanced microbiology lab near Wuhan, the city where the epidemic originated. Since the early days of the crisis, theories have suggested everything from the lab accidentally releasing the virus to speculation that the virus might have been deliberately designed as a biological weapon.

His theory cited as evidence the release of new guidelines from the Chinese Ministry of Science and Technology calling for “strengthening biosecurity management in microbiology labs that handle advanced viruses like the novel coronavirus.”

As Mosher pointed out, the facility near Wuhan is the only Level 4 microbiology lab in China, so the new directive was implicitly directed at the Wuhan facility, which further implies the Ministry of Science and Technology has reason to believe its containment procedures need to be strengthened.

He also noted that Maj. Gen. Chen Wei, the Chinese military’s top expert in biological warfare, was dispatched to Wuhan in January to deal with the crisis, and her background includes extensive research on coronaviruses.

“This would not be her first trip to the Wuhan Institute of Virology, either, since it is one of only two bioweapons research labs in all of China,” he said of Chen’s relationship with the lab.

The novel twist to Mosher’s theory is that Chinese lab technicians have an unfortunate history of selling experimental animals to vendors such as the ones that ply their trade in Wuhan’s wet market:

Instead of properly disposing of infected animals by cremation, as the law requires, they sell them on the side to make a little extra cash. Or, in some cases, a lot of extra cash. One Beijing researcher, now in jail, made a million dollars selling his monkeys and rats on the live animal market, where they eventually wound up in someone’s stomach.
Also fueling suspicions about SARS-CoV-2’s origins is the series of increasingly lame excuses offered by the Chinese authorities as people began to sicken and die.

They first blamed a seafood market not far from the Institute of Virology, even though the first documented cases of Covid-19 (the illness caused by SARS-CoV-2) involved people who had never set foot there. Then they pointed to snakes, bats and even a cute little scaly anteater called a pangolin as the source of the virus.

I don’t buy any of this. It turns out that snakes don’t carry coronaviruses and that bats aren’t sold at a seafood market. Neither, for that matter, are pangolins, an endangered species valued for their scales as much as for their meat.

The evidence points to SARS-CoV-2 research being carried out at the Wuhan Institute of Virology. The virus may have been carried out of the lab by an infected worker or crossed over into humans when they unknowingly dined on a lab animal. Whatever the vector, Beijing authorities are now clearly scrambling to correct the serious problems with the way their labs handle deadly pathogens.

Skepticism about China’s official history of the coronavirus outbreak generally begins with noting that fully a third of the early coronavirus cases documented in December had no connection with the Huanan Seafood Wholesale Market in Wuhan, which closed at the beginning of January after it was identified as ground zero of the epidemic.

The Huanan market certainly looked like the sort of operation that an epidemic might spread from, as it sold seafood and meat alongside live chickens, donkeys, pigs, rats, snakes, and other animals. “Wet markets” derive their name from the practice of killing and butchering live animals while customers watch.

The Wuhan virus appears genetically similar to diseases that have been spread by bats in the past, but there has not been any firm confirmation of which animal might have carried the disease or spread it to humans. In fact, a report published by a Chinese research team on Monday raised questions about whether the virus actually jumped from animals to humans at all.



===

.
 

Ragnarok

On and On, South of Heaven
One person the man had been in contact with and who had developed symptoms of illness flew on a plane to Wisconsin during the 14-day period when she was supposed to be isolated at home."

There is always one asshole who thinks he's so important that the rules don't apply. Like that Oregon comedian who skipped out the back door of his quarantine in Cambodia.

There is no excuse for this kind of behavior. This person needs to be incarcerated and if they develop symptoms, denied any sort of medical care. If they recover, they should be sent to prison for a long time. You do not put the population of this country at risk because of your selfish behavior/desires. Some people just do not deserve the air they breathe.
[/QUOTE]

I wonder where she went in Wisconsin because, I believe, Wisconsin has a confirmed case in Dane County ( Madison )...
 

Terriannie

Has No Life - Lives on TB
I just called my daughter in Texas, with 10 month old twins, because this afternoon the prevailing thought has been "diapers."

She said she didn't believe in the prepping lifestyle, blah blah. I said that China is shut down, and she said she'll just get diapers someplace else. I told her it might not hurt to have some cloth and covers...I am NOT doing cloth diapers!

It was civil, as I know I have to bite my tongue, but I hung up thinking "girl, you're gonna be cutting up old t-shirts and rue the day you blew your mama off."
Oh I know what you're saying. I know. This generation is clueless. Absolutely clueless!!!!
 

Ragnarok

On and On, South of Heaven
Saw on the news this A.M. on Fox news, an Italian gentleman wearing an N-95 mask. Unusual to see this in Italy. Not unusual to see in Asian countries. I guess word is getting around. As everyone has said get what you need now!

Due to the MINISCULE picture sizes we have, now... I couldn't post these but there are many pics in this article of Italians wearing masks.

 
Last edited:

Border Collie Dad

Flat Earther
I just called my daughter in Texas, with 10 month old twins, because this afternoon the prevailing thought has been "diapers."

She said she didn't believe in the prepping lifestyle, blah blah. I said that China is shut down, and she said she'll just get diapers someplace else. I told her it might not hurt to have some cloth and covers...I am NOT doing cloth diapers!

It was civil, as I know I have to bite my tongue, but I hung up thinking "girl, you're gonna be cutting up old t-shirts and rue the day you blew your mama off."

Those pups will get housebroken a little quicker
 

Pinecone

Has No Life - Lives on TB
8 min ago
US senators will be briefed tomorrow on coronavirus
From CNN's Manu Raju

All US senators will be briefed Tuesday morning at 8 a.m. in a classified setting on the novel coronavirus, two sources with knowledge of the plans tell CNN.

One source said that the briefing will be in a classified setting because the senators who are organizing it wanted to be prepared in case a senator asks a question that can only be answered in a classified setting
.
There will be briefers from the Department of Health and Human Services, Department of Homeland Security, Centers for Disease Control and Prevention, National Institutes of Health and the State Department, one source added.


===

.
If anyone in there wants their chance to leak classified info from a Senate briefing, I for one, am all ears.
 

Trivium Pursuit

Has No Life - Lives on TB
There is no excuse for this kind of behavior. This person needs to be incarcerated and if they develop symptoms, denied any sort of medical care. If they recover, they should be sent to prison for a long time. You do not put the population of this country at risk because of your selfish behavior/desires. Some people just do not deserve the air they breathe.

I wonder where she went in Wisconsin because, I believe, Wisconsin has a confirmed case in Dane County ( Madison )...
[/QUOTE]
And epic is in Verona which is a suburb of Madison.
 
You’re Likely to Get the Coronavirus

Most cases are not life-threatening, which is also what makes the virus a historic challenge to contain.
James Hamblin 10:39 AM ET
original.jpg

Xiao Yijiu / Xinhua / eyevine / Redux

In May 1997, a 3-year-old boy developed what at first seemed like the common cold. When his symptoms—sore throat, fever, and cough—persisted for six days, he was taken to the Queen Elizabeth Hospital in Hong Kong. There his cough worsened, and he began gasping for air. Despite intensive care, the boy died.

Puzzled by his rapid deterioration, doctors sent a sample of the boy’s sputum to China’s Department of Health. But the standard testing protocol couldn’t fully identify the virus that had caused the disease. The chief virologist decided to ship some of the sample to colleagues in other countries.

At the U.S. Centers for Disease Control and Prevention in Atlanta, the boy’s sputum sat for a month, waiting for its turn in a slow process of antibody-matching analysis. The results eventually confirmed that this was a variant of influenza, the virus that has killed more people than any in history. But this type had never before been seen in humans. It was H5N1, or “avian flu,” discovered two decades prior, but known only to infect birds.

By then, it was August. Scientists sent distress signals around the world. The Chinese government swiftly killed 1.5 million chickens (over the protests of chicken farmers). Further cases were closely monitored and isolated. By the end of the year there were 18 known cases in humans. Six people died.

This was seen as a successful global response, and the virus was not seen again for years. In part, containment was possible because the disease was so severe: Those who got it became manifestly, extremely ill. H5N1 has a fatality rate of around 60 percent—if you get it, you’re likely to die. Yet since 2003, the virus has killed only 455 people. The much “milder” flu viruses, by contrast, kill fewer than 0.1 percent of people they infect, on average, but are responsible for hundreds of thousands of deaths every year.

Severe illness caused by viruses such as H5N1 also means that infected people can be identified and isolated, or that they died quickly. They do not walk around feeling just a little under the weather, seeding the virus. The new coronavirus (known technically as SARS-CoV-2) that has been spreading around the world can cause a respiratory illness that can be severe. The disease (known as COVID-19) seems to have a fatality rate of less than 2 percent—exponentially lower than most outbreaks that make global news. The virus has raised alarm not despite that low fatality rate, but because of it.

Coronaviruses are similar to influenza viruses in that they are both single strands of RNA. Four coronaviruses commonly infect humans, causing colds. These are believed to have evolved in humans to maximize their own spread—which means sickening, but not killing, people. By contrast, the two prior novel coronavirus outbreaks—SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome, named for where the first outbreak occurred)—were picked up from animals, as was H5N1. These diseases were highly fatal to humans. If there were mild or asymptomatic cases, they were extremely few. Had there been more of them, the disease would have spread widely. Ultimately, SARS and MERS each killed fewer than 1,000 people.

COVID-19 is already reported to have killed more than twice that number. With its potent mix of characteristics, this virus is unlike most that capture popular attention: It is deadly, but not too deadly. It makes people sick, but not in predictable, uniquely identifiable ways. Last week, 14 Americans tested positive on a cruise ship in Japan despite feeling fine—the new virus may be most dangerous because, it seems, it may sometimes cause no symptoms at all.

Read: The new coronavirus is a truly modern epidemic
The world has responded with unprecedented speed and mobilization of resources. The new virus was identified extremely quickly. Its genome was sequenced by Chinese scientists and shared around the world within weeks. The global scientific community has shared genomic and clinical data at unprecedented rates. Work on a vaccine is well under way. The Chinese government enacted dramatic containment measures, and the World Health Organization declared an emergency of international concern. All of this happened in a fraction of the time it took to even identify H5N1 in 1997. And yet the outbreak continues to spread.

The Harvard epidemiology professor Marc Lipsitch is exacting in his diction, even for an epidemiologist. Twice in our conversation he started to say something, then paused and said, “Actually, let me start again.” So it’s striking when one of the points he wanted to get exactly right was this: “I think the likely outcome is that it will ultimately not be containable.”

Containment is the first step in responding to any outbreak. In the case of COVID-19, the possibility (however implausible) of preventing a pandemic seemed to play out in a matter of days. Starting in January, China began cordoning off progressively larger areas, radiating outward from Wuhan City and eventually encapsulating some 100 million people. People were barred from leaving home, and lectured by drones if they were caught outside. Nonetheless, the virus has now been found in 24 countries.

Despite the apparent ineffectiveness of such measures—relative to their inordinate social and economic cost, at least—the crackdown continues to escalate. Under political pressure to “stop” the virus, last Thursday the Chinese government announced that officials in the Hubei province would be going door to door, testing people for fevers and looking for signs of illness, then sending all potential cases to quarantine camps. But even with the ideal containment, the virus’s spread may have been inevitable. Testing people who are already extremely sick is an imperfect strategy if people can spread the virus without even feeling bad enough to stay home from work.

Lipsitch predicts that, within the coming year, some 40 to 70 percent of people around the world will be infected with the virus that causes COVID-19. But, he clarifies emphatically, this does not mean that all will have severe illnesses. “It’s likely that many will have mild disease, or may be asymptomatic,” he said. As with influenza, which is often life-threatening to people with chronic health conditions and of older age, most cases pass without medical care. (Overall, around 14 percent of people with influenza have no symptoms.)

Lipsitch is far from alone in his belief that this virus will continue to spread widely. The emerging consensus among epidemiologists is that the most likely outcome of this outbreak is a new seasonal disease—a fifth “endemic” coronavirus. With the other four, people are not known to develop long-lasting immunity. If this one follows suit, and if the disease continues to be as severe as it is now, “cold and flu season” could become “cold and flu and COVID-19 season.”

At this point, it is not even known how many people are infected. As of Sunday, there have been 35 confirmed cases in the U.S., according to the World Health Organization. But Lipsitch’s “very, very rough” estimate when we spoke a week ago (banking on “multiple assumptions piled on top of each other,” he said) was that 100 or 200 people in the U.S. were infected. That’s all it would take to seed the disease widely. The rate of spread would depend on how contagious the disease is in milder cases. On Friday, Chinese scientists reported in the medical journal JAMA an apparent case of asymptomatic spread of the virus, from a patient with a normal chest CT scan. The researchers concluded with stolid understatement that if this finding is not a bizarre abnormality, “the prevention of COVID-19 infection would prove challenging.”

Read: 20 seconds to optimize hand wellness
Even if Lipsitch’s estimates were off by orders of magnitude, they wouldn’t likely change the overall prognosis. “Two hundred cases of a flu-like illness during flu season—when you’re not testing for it—is very hard to detect,” Lipsitch said. “But it would be really good to know sooner rather than later whether that’s correct, or whether we’ve miscalculated something. The only way to do that is by testing.”

Originally, doctors in the U.S. were advised not to test people unless they had been to China or had contact with someone who had been diagnosed with the disease. Within the past two weeks, the CDC said it would start screening people in five U.S. cities, in an effort to give some idea of how many cases are actually out there. But tests are still not widely available. As of Friday, the Association of Public Health Laboratories said that only California, Nebraska, and Illinois had the capacity to test people for the virus.

With so little data, prognosis is difficult. But the concern that this virus is beyond containment—that it will be with us indefinitely—is nowhere more apparent than in the global race to find a vaccine, one of the clearest strategies for saving lives in the years to come.

Over the past month, stock prices of a small pharmaceutical company named Inovio more than doubled. In mid-January, it reportedly discovered a vaccine for the new coronavirus. This claim has been repeated in many news reports, even though it is technically inaccurate. Like other drugs, vaccines require a long testing process to see if they indeed protect people from disease, and do so safely. What this company—and others—has done is copy a bit of the virus’s RNA that one day could prove to work as a vaccine. It’s a promising first step, but to call it a discovery is like announcing a new surgery after sharpening a scalpel.

Though genetic sequencing is now extremely fast, making vaccines is as much art as science. It involves finding a viral sequence that will reliably cause a protective immune-system memory but not trigger an acute inflammatory response that would itself cause symptoms. (While the influenza vaccine cannot cause the flu, CDC warns that it can cause “flu-like symptoms.”) Hitting this sweet spot requires testing, first in lab models and animals, and eventually in people. One does not simply ship a billion viral gene fragments around the world to be injected into everyone at the moment of discovery.

Inovio is far from the only small biotech company venturing to create a sequence that strikes that balance. Others include Moderna, CureVac, and Novavax. Academic researchers are also on the case, at Imperial College London and other universities, as are federal scientists in several countries, including at the U.S. National Institutes of Health. Anthony Fauci, head of the NIH’s National Institute of Allergy and Infectious Diseases, wrote in JAMA in January that the agency was working at historic speed to find a vaccine. During the SARS outbreak in 2003, researchers moved from obtaining the genomic sequence of the virus and into a phase 1 clinical trial of a vaccine in 20 months. Fauci wrote that his team has since compressed that timeline to just over three months for other viruses, and for the new coronavirus, “they hope to move even faster.”

New models have sprung up in recent years, too, that promise to speed up vaccine development. One is the Coalition for Epidemic Preparedness (CEPI), which was launched in Norway in 2017 to finance and coordinate the development of new vaccines. Its founders include the governments of Norway and India, the Wellcome Trust, and the Bill & Melinda Gates Foundation. The group’s money is now flowing to Inovio and other small biotech start-ups, encouraging them to get into the risky business of vaccine development. The group’s CEO, Richard Hatchett, shares Fauci’s basic timeline vision—a COVID-19 vaccine ready for early phases of safety testing in April. If all goes well, by late summer testing could begin to see if the vaccine actually prevents disease.
Read: Coronavirus is devastating Chinese tourism

continued:

===
 
You’re Likely to Get the Coronavirus - continued

Overall, if all pieces fell into place, Hatchett guesses it would be 12 to 18 months before an initial product could be deemed safe and effective. That timeline represents “a vast acceleration compared with the history of vaccine development,” he told me. But it’s also unprecedentedly ambitious. “Even to propose such a timeline at this point must be regarded as hugely aspirational,” he added.

Even if that idyllic year-long projection were realized, the novel product would still require manufacturing and distribution. “An important consideration is whether the underlying approach can then be scaled to produce millions or even billions of doses in coming years,” Hatchett said. Especially in an ongoing emergency, if borders closed and supply chains broke, distribution and production could prove difficult purely as a matter of logistics.

Fauci’s initial optimism seemed to wane, too. Last week he said that the process of vaccine development was proving “very difficult and very frustrating.” For all the advances in basic science, the process cannot proceed to an actual vaccine without extensive clinical testing, which requires manufacturing many vaccines and meticulously monitoring outcomes in people. The process could ultimately cost hundreds of millions of dollars—money that the NIH, start-ups, and universities don’t have. Nor do they have the production facilities and technology to mass-manufacture and distribute a vaccine.

Production of vaccines has long been contingent on investment from one of the handful of giant global pharmaceutical companies. At the Aspen Institute last week, Fauci lamented that none had yet to “step up” and commit to making the vaccine. “Companies that have the skill to be able to do it are not going to just sit around and have a warm facility, ready to go for when you need it,” he said. Even if they did, taking on a new product like this could mean massive losses, especially if the demand faded or if people, for complex reasons, chose not to use the product.

Making vaccines is so difficult, cost intensive, and high risk that in the 1980s, when drug companies began to incur legal costs over alleged harms caused by vaccines, many opted to simply quit making them. To incentivize the pharmaceutical industry to keep producing these vital products, the U.S. government offered to indemnify anyone claiming to have been harmed by a vaccine. The arrangement continues to this day. Even still, drug companies have generally found it more profitable to invest in the daily-use drugs for chronic conditions. And coronaviruses could present a particular challenge in that at their core they are, like influenza viruses, a single strand of RNA. This viral class is likely to mutate, and vaccines may need to be in constant development, as with the flu.

“If we’re putting all our hopes in a vaccine as being the answer, we’re in trouble,” Jason Schwartz, an assistant professor at Yale School of Public Health who studies vaccine policy, told me. The best-case scenario, as Schwartz sees it, is the one in which this vaccine development happens far too late to make a difference for the current outbreak. The real problem is that preparedness for this outbreak should have been happening for the past decade, ever since SARS. “Had we not set the SARS-vaccine-research program aside, we would have had a lot more of this foundational work that we could apply to this new, closely related virus, ” he said. But, as with Ebola, government funding and pharmaceutical-industry development evaporated once the sense of emergency lifted. “Some very early research ended up sitting on a shelf because that outbreak ended before a vaccine needed to be aggressively developed.”

On Saturday, Politico reported that the White House is preparing to ask Congress for $1 billion in emergency funding for a coronavirus response. This request, if it materialized, would come in the same month in which President Donald Trump released a new budget proposal that would cut key elements of pandemic preparedness—funding for the CDC, the NIH, and foreign aid.

Thomas J. Bollyky: Coronavirus is spreading because humans are healthier
These long-term government investments matter because creating vaccines, antiviral medications, and other vital tools requires decades of serious investment, even when demand is low. Market-based economies often struggle to develop a product for which there is no immediate demand and to distribute products to the places they’re needed. CEPI has been touted as a promising model to incentivize vaccine development before an emergency begins, but the group also has skeptics. Last year, Doctors Without Borders wrote a scathing open letter, saying the model didn’t ensure equitable distribution or affordability. CEPI subsequently updated its policies to forefront equitable access, and Manuel Martin, a medical innovation and access adviser with Doctors Without Borders, told me last week that he’s now cautiously optimistic. “CEPI is absolutely promising, and we really hope that it will be successful in producing a novel vaccine,” he said. But he and his colleagues are “waiting to see how CEPI’s commitments play out in practice.”

These considerations matter not simply as humanitarian benevolence, but also as effective policy. Getting vaccines and other resources to the places where they will be most helpful is essential to stop disease from spreading widely. During the 2009 H1N1 flu outbreak, for example, Mexico was hit hard. In Australia, which was not, the government prevented exports by its pharmaceutical industry until it filled the Australian government’s order for vaccines. The more the world enters lockdown and self-preservation mode, the more difficult it could be to soberly assess risk and effectively distribute tools, from vaccines and respirator masks to food and hand soap.

Italy, Iran, and South Korea are now among the countries reporting quickly growing numbers of detected COVID-19 infections. Many countries have responded with containment attempts, despite the dubious efficacy and inherent harms of China’s historically unprecedented crackdown. Certain containment measures will be appropriate, but widely banning travel, closing down cities, and hoarding resources are not realistic solutions for an outbreak that lasts years. All of these measures come with risks of their own. Ultimately some pandemic responses will require opening borders, not closing them. At some point the expectation that any area will escape effects of COVID-19 must be abandoned: The disease must be seen as everyone’s problem.

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.

James Hamblin, MD, is a staff writer at The Atlantic. He hosts the video series If Our Bodies Could Talk and is the author of a book by the same title. | More

===

.
 

Hfcomms

EN66iq
NY Times reporter's twitter feed:

Farnaz Fassihi
@farnazfassihi

#Iran coronavirus: Dr. Ghadir, top health official in Qom now infected, tells State TV: The health ministry ordered Qom officials "not to publish statistics" related to coronavirus. Wow.


All governments are alike in this manner. Pacify the sheep, keep them calm and orderly and then lie thru your teeth for the greater good. They will tell you everything is fine and under control even when it’s obvious it isn’t. Those that are proactive and read between the lines won’t get caught with their pants down. Those that don’t will be in a world of hurt.
 

vector7

Dot Collector
Expert: Chinese Scientists Sell Lab Animals as Meat on the Black Market

Flashbacks:
USDA Allows China to Process U.S. Chicken

By Charlotte Hilton Andersen

image


"Chinese chicken" will soon have a whole new meaning, as the U.S. Department of Agriculture recently gave the green-light to four chicken processing plants in China, allowing chicken raised and slaughtered in the U.S. to be exported to China for processing, and then shipped back to the U.S. and sold on grocery shelves here.

The actual arrangement will take some time to set in, however. "All this means is that we've deemed China's poultry processing equivalent to the process in the United States," says Arianne Perkins, USDA public affairs specialist. Individual companies will still have to be certified, something Perkins says has not happened yet.

While the logistics are hard to imagine-if we can't safely leave chicken out for the length of a family picnic, how can it be shipped halfway around the world and back with no ill effects?-the USDA is doing its best to reassure both chicken farmers and consumers that the process is 100-percent safe.

"The Food Safety and Inspection Service's number-one priority is always food safety," Perkins says. In the official memo, the FSIS says that "all outstanding issues have been resolved"-a pretty big promise considering that in the past year alone China has made news for passing off rat meat as mutton, selling sausages filled with maggots, inexplicably finding thousands of dead pigs floating in the waters of Shanghai, and even having an outbreak of the H7N9 bird flu in live poultry.

"We do have a concern about safety," National Chicken Council senior vice president Bill Roenigk said in a statement. "But we've been assured and reassured by the USDA that they will do 100-percent testing on poultry products from China. We have confidence that the USDA will do that testing and do it in a good and adequate manner."

However Perkins adds that while there will be increased testing on the chicken before re-entering the U.S., they will not be doing any on-site monitoring or testing in China, a fact that Rep. Rosa De Lauro (D-Conn.) said in a statement is "deeply worrisome" for American consumers. Even worse, a report just this month from the United States Government Accountability Office found that the USDA's domestic poultry inspections have a lot of problems anyhow, as they are in the process of replacing certified-USDA inspectors with those provided by the poultry companies themselves.

In addition to the concerns that this decision could open the door for even more unsafe practices, no country-of-origin labels are required under the new rules, so consumers won't know where their bird is coming from. Plus industry insiders warn that the move is politically motivated by a desire to get China to re-allow lucrative U.S. beef imports and will likely lead to allowing imports of Chinese chickens, a practice that's been banned since bird flu and other food safety concerns first surfaced.

All of this has many recommending to buy local so you know your dinner is safe and 100-percent all-American.


USDA to Allow Chickens From U.S. to Be Shipped to China for Processing and Back to U.S. for Consumption, Just Like Seafood


John Deike

Mar. 05, 2014 09:03AM EST

Scores of Americans are in an uproar since Food Safety News revealed the U.S. Department of Agriculture (USDA) will soon allow U.S. chickens to be sent to China for processing before being shipped back to the states for human consumption.

Bureau of Labor Statistics data estimates that American poultry processors are paid roughly $11 per hour on average. In China, reports have circulated that the country's chicken workers can earn significantly less—$1 to 2 per hour.

This arrangement is especially disturbing given China's subpar food safety record and the fact that there are no plans to station on-site USDA inspectors at Chinese plants. Also, American consumers won't know which brands of chicken are processed in China because there's no requirement to label it as such.

To ease concerns, lobbyists and chicken industry proponents argue no U.S. company will ever ship chicken to China for processing because it wouldn't work economically.

“Economically, it doesn't make much sense," said Tom Super, spokesman for the National Chicken Council, in a recent interview with the Houston Chronicle. "Think about it: A Chinese company would have to purchase frozen chicken in the U.S., pay to ship it 7,000 miles, unload it, transport it to a processing plant, unpack it, cut it up, process/cook it, freeze it, repack it, transport it back to a port, then ship it another 7,000 miles. I don't know how anyone could make a profit doing that."

Yet, a similar process is already being used for U.S. seafood.

According to the Seattle Times, domestically caught Pacific salmon and Dungeness crab are being processed in China and shipped back to the U.S. because of significant cost savings.

“There are 36 pin bones in a salmon and the best way to remove them is by hand," said Charles Bundrant, founder of Trident, which ships about 30 million pounds of its 1.2 billion-pound annual harvest to China for processing. “Something that would cost us $1 per pound labor here, they get it done for 20 cents in China."

Bureau of Labor Statistics data estimates that American poultry processors are paid roughly $11 per hour on average. In China, reports have circulated that the country's chicken workers can earn significantly less—$1 to 2 per hour—which casts doubt on Super's economic feasibility assessment.

China's food safety system, which is said to be decades behind America's, is highly questionable given some of the more recent food safety scandals that have surfaced in the country:
Food Safety News aims to spread awareness of the pending USDA agreement and stop Chinese-processed chicken from ever reaching supermarkets or school lunchrooms.
 

raven

TB Fanatic
The last day of the month is the 29th, that is Saturday.
Military and lots of other people will get paid on Friday.
Thursday of this week might be a good day. Friday could be sparse depending on where you live.
check your local FB Market Place or Buy Sell Trade and see what people are selling.
It is winter. Seasonal job lull. End of month.
You might pick up some of those last minute items you need - cheap
 

Ragnarok

On and On, South of Heaven
Many other infection hot spots in the world, they are getting plenty press.

Yet we have it all under control in CONUS?




Trump asserts coronavirus 'under control'
President Trump asserted Monday that the coronavirus is “very much under control” in the United States, even as stock markets plunged amid concerns about the spread of the virus.

“The Coronavirus is very much under control in the USA. We are in contact with everyone and all relevant countries,” Trump, who is traveling on official business in India, tweeted. “CDC & World Health have been working hard and very smart. Stock Market starting to look very good to me!”



The Coronavirus is very much under control in the USA. We are in contact with everyone and all relevant countries. CDC & World Health have been working hard and very smart. Stock Market starting to look very good to me!
— Donald J. Trump (@realDonaldTrump) February 24, 2020



The Dow Jones Industrial Average fell 1,031 points on Monday, one of its largest single-day drops in terms of points, as concerns rose about the spread of the coronavirus beyond China.

Trump has sought to project confidence in the steps his administration has taken to contain and mitigate the outbreak as cases are reported in the U.S. and at times has seemed to downplay the threat.

The White House is expected to ask Congress for emergency funding to combat the virus, which is believed to have originated in the Chinese city of Wuhan, though it’s unclear yet how much.

There have been a handful of confirmed cases of the virus in the U.S., but it is not spreading among the general public. A number of countries, including Italy and Iran, reported considerable increases in confirmed cases over the weekend.

The Trump administration set up a coronavirus task force in late January and implemented a quarantine and travel restrictions in order to mitigate the spread of the virus. White House principal deputy press secretary Hogan Gidley told reporters at the White House earlier Monday that Trump continues to be briefed on the topic daily.

“The president’s concerns are always the safety and security of the American people, and so in this instance, because he has taken such aggressive action, because he does continue to receive briefings on a daily basis, he just wants to ensure the spread of this virus does not move quickly in this country at all,” Gidley said.
 
Field Report:

Went to local Home depot > all dust related type masks (even in paint section ) sold, with a with sign sayng "due to events this product is sold out".
All other behavior normal

Went to Target:
Saw a VERY large black guy buying lots of isopropyl alcohol, said his wife told him to "go get some".
All other behavior shopping cart items appeared "normal".
 
Live in process - started 30 minutes ago:

View: https://www.youtube.com/watch?v=fLYnomkC1fA

Coronavirus: Time To Prepare Is Running Out
16,094 watching now
•Premiere in progress. Started 31 minutes ago


Peak Prosperity
205K subscribe

OK...despite more worldwide infections than ever, the WHO has decided to stop using the (technically very accurate) term "pandemic" to describe covid-19, presumably because they don't want to scare folks.

The CDC is claiming that the US is not seeing "community level" spreading of the virus. But of course it isn't, because it's NOT testing at the community level. And only 3 US states currently have the capacity to run such tests, due to faulty kits being provided to the other states.

Then there's State Department's botched rescue of US citizens stuck on the Diamond Princess cruise ship, during which poor safety controls allowed 25 more folks to get infected on the flight back to the US. And these are the authorities we're depending on??

China, meanwhile, is lowering response levels in several provinces, setting the stage for workers to head back to the factories. BUT...they've postponed the National People's Conference.
So, it's still too serious for the the 'important' people to be in public, but the plebes have nothing to worry about?? China is facing a lose-lose decision: maintain their widespread quarantines to contain the virus, but kill their economy? Or send people back to work, and risk infecting millions more?

Today, the markets *finally* started to show concern for the hit global trade is taking from this growing crisis. If the euphoria pushing markets to new highs is dissipating, there is an awful lot of empty space below today's asset prices compared to their fundamentals-based valuations. Translation = the markets can fall a LOT farther from here.

To reiterate our guidance: the time to prepare -- physically and financially -- is NOW. As China, Italy, South Korea, Iran and other countries are showing us, a government lockdown happens swiftly, slamming shut your window to act. Use the time you still have as the precious gift it is, and strengthen your preparations.

===

.
 

desertvet2

Veteran Member
Gonna be sad to see the napalm runs throughout the homeless camps, but....if you need it done, burn it with gellified fuel.

Odds are though...that won't happen....
 

raven

TB Fanatic
Trump asserts coronavirus 'under control'
President Trump asserted Monday that the coronavirus is “very much under control” in the United States, even as stock markets plunged amid concerns about the spread of the virus.

“The Coronavirus is very much under control in the USA. We are in contact with everyone and all relevant countries,” Trump, who is traveling on official business in India, tweeted. “CDC & World Health have been working hard and very smart. Stock Market starting to look very good to me!”







The Dow Jones Industrial Average fell 1,031 points on Monday, one of its largest single-day drops in terms of points, as concerns rose about the spread of the coronavirus beyond China.

Trump has sought to project confidence in the steps his administration has taken to contain and mitigate the outbreak as cases are reported in the U.S. and at times has seemed to downplay the threat.

The White House is expected to ask Congress for emergency funding to combat the virus, which is believed to have originated in the Chinese city of Wuhan, though it’s unclear yet how much.

There have been a handful of confirmed cases of the virus in the U.S., but it is not spreading among the general public. A number of countries, including Italy and Iran, reported considerable increases in confirmed cases over the weekend.

The Trump administration set up a coronavirus task force in late January and implemented a quarantine and travel restrictions in order to mitigate the spread of the virus. White House principal deputy press secretary Hogan Gidley told reporters at the White House earlier Monday that Trump continues to be briefed on the topic daily.

“The president’s concerns are always the safety and security of the American people, and so in this instance, because he has taken such aggressive action, because he does continue to receive briefings on a daily basis, he just wants to ensure the spread of this virus does not move quickly in this country at all,” Gidley said.
hey, look at the bright side, you have another day to prep
 

Ragnarok

On and On, South of Heaven
View: https://www.youtube.com/watch?v=Q7-KN-52GxU

RT 01:00
Long Lines For Face Masks In City At Center Of South Korea’s Coronavirus Crisis | NBC News
4,104 views
•Feb 24, 2020
1.88M subscribers
Drone video provided by South Korean media showed customers waiting in line outside an E-mart store on Monday morning. E-mart began to sell 1.41 million face masks at half price in Daegu, according to local media reports.

===

.

Good Lord... And, how many in that line are shedding the virus? You would think it obvious to avoid crowds...
 

Ragnarok

On and On, South of Heaven
Last edited:

summerthyme

Administrator
_______________
If that is not the markings of a virus capable of creating a global pandemic, what is?
Er... wasn't it WHO who was saying that stopping flights and forbidding from entering countries based solely on their country of origin "was unnecessary"?!

(Sorry.... the wrong quote showed up! I meant to quote a statement by WHO blaming Italy for not immediately shutting down their borders, etc)

Summerthyme
 
Last edited:

night driver

ESFP adrift in INTJ sea
EPIC is the software that runs the record keeping function for a surprising majority of hospitals in the US and in a number of other countries.

I've worked in an EPIC hospital (Cleveland Clinic (in ALL their facilities)) and a NON EPIC hospital (UH Case). Now, UH-Case-Rainbow MAY have converted as it's been a few years.

If EPIC sneezes, half of the hospitals in the US show signs of pneumonia.
 

DuckandCover

Proud Sheeple
I would assume this has been discussed here, but I don't recall it. Regardless, this is kind of interesting. Accurate? I dunno, just throwing it out there:



COVID-19 Fatality Rate by AGE:
*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%). This probability differs depending on the age group. The percentage shown below does NOT represent in any way the share of deaths by age group. Rather, it represents, for a person in a given age group, the risk of dying if infected with COVID-19.
AGE​
DEATH RATE*
80+ years old
14.8%
70-79 years old
8.0%
60-69 years old
3.6%
50-59 years old
1.3%
40-49 years old
0.4%
30-39 years old
0.2%
20-29 years old
0.2%
10-19 years old
0.2%
0-9 years old
no fatalities
*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%).

In general, relatively few cases are seen among children.

COVID-19 Fatality Rate by SEX:
*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%). This probability differs depending on sex. When reading these numbers, it must be taken into account that smoking in China is much more prevalent among males. Smoking increases the risks of respiratory complications.
SEX​
DEATH RATE *
Male
2.8%
Female
1.7%
*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%).

Pre-existing medical conditions (comorbidities)
Patients who reported no pre-existing ("comorbid") medical conditions had a case fatality rate of 0.9%. Pre-existing illnesses that put patients at higher risk of dying from a COVID-19 infection are:
COVID-19 Fatality Rate by COMORBIDITY:
*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%). This probability differs depending on pre-existing condition. The percentage shown below does NOT represent in any way the share of deaths by pre-existing condition. Rather, it represents, for a patient with a given pre-existing condition, the risk of dying if infected by COVID-19.
PRE-EXISTING CONDITION​
DEATH RATE*
Cardiovascular disease
10.5%
Diabetes
7.3%
Chronic respiratory disease
6.3%
Hypertension
6.0%
Cancer
5.6%
no pre-existing conditions
0.9%
*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%).
 
Top